Raymond Chang1, Khaled Mossad Elhusseiny2, Yu-Chang Yeh3, Wei-Zen Sun1,3. 1. Institute of East-West Medicine, New York, New York, United States of America. 2. Faculty of Medicine, Al-Azhar University, Cairo, Egypt. 3. Department of Anesthesia, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
BACKGROUND: Insight into COVID-19 intensive care unit (ICU) patient characteristics, rates and risks of invasive mechanical ventilation (IMV) and associated outcomes as well as any regional discrepancies is critical in this pandemic for individual case management and overall resource planning. METHODS AND FINDINGS: Electronic searches were performed for reports through May 1 2020 and reports on COVID-19 ICU admissions and outcomes were included using predefined search terms. Relevant data was subsequently extracted and pooled using fixed or random effects meta-analysis depending on heterogeneity. Study quality was assessed by the NIH tool and heterogeneity was assessed by I2 and Q tests. Baseline patient characteristics, ICU and IMV outcomes were pooled and meta-analyzed. Pooled odds ratios (pOR) were calculated for clinical features against ICU, IMV mortality. Subgroup analysis was carried out based on patient regions. A total of twenty-eight studies comprising 12,437 COVID-19 ICU admissions from seven countries were meta-analyzed. Pooled ICU admission rate was 21% [95% CI 0.12-0.34] and 69% of cases needed IMV [95% CI 0.61-0.75]. ICU and IMV mortality were 28.3% [95% CI 0.25-0.32], 43% [95% CI 0.29-0.58] and ICU, IMV duration was 7.78 [95% CI 6.99-8.63] and 10.12 [95% CI 7.08-13.16] days respectively. Besides confirming the significance of comorbidities and clinical findings of COVID-19 previously reported, we found the major correlates with ICU mortality were IMV [pOR 16.46, 95% CI 4.37-61.96], acute kidney injury (AKI) [pOR 12.47, 95% CI 1.52-102.7], and acute respiratory distress syndrome (ARDS) [pOR 6.52, 95% CI 2.66-16.01]. Subgroup analyses confirm significant regional discrepancies in outcomes. CONCLUSIONS: This is a comprehensive systematic review and meta-analysis of COVID-19 ICU and IMV cases and associated outcomes. The significant association of AKI, ARDS and IMV with mortality has implications for ICU resource planning for AKI and ARDS as well as suggesting the need for further research into optimal ventilation strategies for COVID-19 patients in the ICU setting. Regional differences in outcome implies a need to develop region specific protocols for ventilatory support as well as overall treatment.
BACKGROUND: Insight into COVID-19 intensive care unit (ICU) patient characteristics, rates and risks of invasive mechanical ventilation (IMV) and associated outcomes as well as any regional discrepancies is critical in this pandemic for individual case management and overall resource planning. METHODS AND FINDINGS: Electronic searches were performed for reports through May 1 2020 and reports on COVID-19 ICU admissions and outcomes were included using predefined search terms. Relevant data was subsequently extracted and pooled using fixed or random effects meta-analysis depending on heterogeneity. Study quality was assessed by the NIH tool and heterogeneity was assessed by I2 and Q tests. Baseline patient characteristics, ICU and IMV outcomes were pooled and meta-analyzed. Pooled odds ratios (pOR) were calculated for clinical features against ICU, IMV mortality. Subgroup analysis was carried out based on patient regions. A total of twenty-eight studies comprising 12,437 COVID-19 ICU admissions from seven countries were meta-analyzed. Pooled ICU admission rate was 21% [95% CI 0.12-0.34] and 69% of cases needed IMV [95% CI 0.61-0.75]. ICU and IMV mortality were 28.3% [95% CI 0.25-0.32], 43% [95% CI 0.29-0.58] and ICU, IMV duration was 7.78 [95% CI 6.99-8.63] and 10.12 [95% CI 7.08-13.16] days respectively. Besides confirming the significance of comorbidities and clinical findings of COVID-19 previously reported, we found the major correlates with ICU mortality were IMV [pOR 16.46, 95% CI 4.37-61.96], acute kidney injury (AKI) [pOR 12.47, 95% CI 1.52-102.7], and acute respiratory distress syndrome (ARDS) [pOR 6.52, 95% CI 2.66-16.01]. Subgroup analyses confirm significant regional discrepancies in outcomes. CONCLUSIONS: This is a comprehensive systematic review and meta-analysis of COVID-19 ICU and IMV cases and associated outcomes. The significant association of AKI, ARDS and IMV with mortality has implications for ICU resource planning for AKI and ARDS as well as suggesting the need for further research into optimal ventilation strategies for COVID-19patients in the ICU setting. Regional differences in outcome implies a need to develop region specific protocols for ventilatory support as well as overall treatment.
Authors: Anwar Khedr; Hussam Al Hennawi; Ibtisam Rauf; Muhammad Khuzzaim Khan; Hisham A Mushtaq; Hana Sultana Lodhi; Juan Pablo Domecq Garces; Nitesh K Jain; Thoyaja Koritala; Syed Anjum Khan Journal: Infez Med Date: 2022-03-01
Authors: André Dos Santos Rocha; John Diaper; Adam L Balogh; Christophe Marti; Olivier Grosgurin; Walid Habre; Ferenc Peták; Roberta Südy Journal: Sci Rep Date: 2022-06-30 Impact factor: 4.996
Authors: Konstantinos Dimitriadis; Jan Meis; Hermann Neugebauer; Kristian Barlinn; Bernhard Neumann; Georg Gahn; Piergiorgio Lochner; Benjamin Knier; Sarah Lindemann; Kurt Wolfram Sühs; Kristina Szabo; Thomas Pfefferkorn; Ingo Schirotzek; Tobias Freilinger; Bassa Burc; Albrecht Günther; Matthias Wittstock; Patrick Schramm; Gernot Reimann; Jana Godau; Gabor Nagy; Fatima B Koenig; Fabian Essig; Hartwig Klinker; Christian Hartmann; Moritz L Schmidbauer; Tim Steinberg; Lora Lefterova; Christina Klose; Julian Bösel Journal: Crit Care Date: 2022-07-16 Impact factor: 19.334
Authors: Stephanie L Harrison; Benjamin J R Buckley; José Miguel Rivera-Caravaca; Juqian Zhang; Gregory Y H Lip Journal: Eur Heart J Qual Care Clin Outcomes Date: 2021-07-21
Authors: Vibe S Mikkelsen; Marie Helleberg; Nicolai Haase; Morten H Møller; Anders Granholm; Merete Storgaard; Andreas B Jonsson; Kristian Schønning; Nanna Reiter; Sigurður Þór Sigurðsson; Marianne Voldstedlund; Steffen Christensen; Anders Perner Journal: Acta Anaesthesiol Scand Date: 2021-06-23 Impact factor: 2.274
Authors: Balazs P Vagvolgyi; Mikhail Khrenov; Jonathan Cope; Anton Deguet; Peter Kazanzides; Sajid Manzoor; Russell H Taylor; Axel Krieger Journal: Front Robot AI Date: 2021-06-24